| Literature DB >> 3144299 |
K G Feitsma1, D S Postma, G H Koëter, G D Nossent, B F Brenth, R A de Zeeuw.
Abstract
1. Racemic oxyphenonium bromide, its enantiomers and placebo were inhaled by eight adult patients with chronic airflow obstruction, in a four-way double-blind cross-over study. 2. Forced expiratory volume in one second (FEV1) and slow inspiratory vital capacity (VC) were measured during the first 6 h after inhalation. 3. (+)-Oxyphenonium was found to be the active enantiomer (eutomer), providing better bronchodilation than (+/-)-oxyphenonium. 4. The distomer, (-)-oxyphenonium, showed only a slight effect on FEV1 and VC as compared with placebo.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3144299 PMCID: PMC1386444 DOI: 10.1111/j.1365-2125.1988.tb05253.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335